{"retracted":false,"update":{"timestamp":1458518400000,"doi":"10.1371/journal.pone.0152341","type":"correction"},"doi":"10.1371/journal.pone.0145468","journal":"PLOS ONE","publisher":"Public Library of Science (PLoS)","title":"Correction: Baseline Serum Osteopontin Levels Predict the Clinical Effectiveness of Tocilizumab but Not Infliximab in Biologic-Na√Øve Patients with Rheumatoid Arthritis: A Single-Center Prospective Study at 1 Year (the Keio First-Bio Cohort Study)"}
